25.2618 USD
-0.04 (-0.15%)
Taking everything into account, CHSCN scores 3 out of 10 in our fundamental rating. CHSCN was compared to 87 industry peers in the Food Products industry. CHSCN has a medium profitability rating, but doesn't score so well on its financial health evaluation. CHSCN has a expensive valuation and it also scores bad on growth. CHSCN also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
CHSCN had a positive operating cash flow in the past year.
Each year in the past 5 years CHSCN has been profitable.
CHSCN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of CHSCN (3.17%) is better than 60.47% of its industry peers.
The Return On Equity of CHSCN (5.40%) is comparable to the rest of the industry.
CHSCN's Return On Invested Capital of 0.49% is in line compared to the rest of the industry. CHSCN outperforms 41.86% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CHSCN is significantly below the industry average of 28.26%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 5.4% | ||
| ROIC | 0.49% |
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
1.3 Margins
CHSCN has a Profit Margin (1.69%) which is in line with its industry peers.
In the last couple of years the Profit Margin of CHSCN has grown nicely.
CHSCN has a Operating Margin of 0.26%. This is comparable to the rest of the industry: CHSCN outperforms 40.70% of its industry peers.
In the last couple of years the Operating Margin of CHSCN has declined.
CHSCN has a Gross Margin of 3.21%. This is amonst the worse of the industry: CHSCN underperforms 86.05% of its industry peers.
In the last couple of years the Gross Margin of CHSCN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.26% | ||
| PM (TTM) | 1.69% | ||
| GM | 3.21% |
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
2. Health
2.1 Basic Checks
CHSCN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CHSCN has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.32 indicates that CHSCN is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.32, CHSCN perfoms like the industry average, outperforming 52.33% of the companies in the same industry.
CHSCN has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.26, CHSCN is doing good in the industry, outperforming 65.12% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.32 |
ROIC/WACC0.09
WACC5.45%
2.3 Liquidity
CHSCN has a Current Ratio of 1.53. This is a normal value and indicates that CHSCN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.53, CHSCN perfoms like the industry average, outperforming 47.67% of the companies in the same industry.
A Quick Ratio of 0.91 indicates that CHSCN may have some problems paying its short term obligations.
CHSCN has a Quick ratio (0.91) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.53 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
CHSCN shows a decrease in Revenue. In the last year, the revenue decreased by -9.68%.
The Revenue has been growing slightly by 4.54% on average over the past years.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-9.68%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-6.19%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CHSCN is valued cheaper than 95.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 2.45 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 7.02%, CHSCN is a good candidate for dividend investing.
CHSCN's Dividend Yield is rather good when compared to the industry average which is at 2.41. CHSCN pays more dividend than 90.70% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, CHSCN pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.02% |
5.2 History
CHSCN has paid a dividend for at least 10 years, which is a reliable track record.
CHSCN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years10
5.3 Sustainability
CHSCN pays out 28.20% of its income as dividend. This is a sustainable payout ratio.
DP28.2%
EPS Next 2YN/A
EPS Next 3YN/A
NASDAQ:CHSCN (12/12/2025, 8:20:19 PM)
25.2618
-0.04 (-0.15%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners11.45%
Inst Owner Change1043.08%
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap309.96M
Revenue(TTM)35.46B
Net Income(TTM)598.13M
Analysts0
Price TargetN/A
Short Float %0.03%
Short Ratio0.19
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.02% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP28.2%
Div Incr Years0
Div Non Decr Years10
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.01 | ||
| P/FCF | N/A | ||
| P/OCF | 0.49 | ||
| P/B | 0.03 | ||
| P/tB | 0.03 | ||
| EV/EBITDA | 2.45 |
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-7.56
FCFYN/A
OCF(TTM)51.82
OCFY205.12%
SpS2890.18
BVpS902.75
TBVpS902.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 5.4% | ||
| ROCE | 0.67% | ||
| ROIC | 0.49% | ||
| ROICexc | 0.5% | ||
| ROICexgc | 0.5% | ||
| OM | 0.26% | ||
| PM (TTM) | 1.69% | ||
| GM | 3.21% | ||
| FCFM | N/A |
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
ROICexc(3y)4.33%
ROICexc(5y)4.38%
ROICexgc(3y)4.41%
ROICexgc(5y)4.46%
ROCE(3y)5.12%
ROCE(5y)5.34%
ROICexgc growth 3Y-59.71%
ROICexgc growth 5Y-22%
ROICexc growth 3Y-59.75%
ROICexc growth 5Y-22.29%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
F-Score5
Asset Turnover1.88
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.9 | ||
| Cap/Depr | 111.84% | ||
| Cap/Sales | 2.05% | ||
| Interest Coverage | 0.62 | ||
| Cash Conversion | 85.64% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.53 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 2.32 |
F-Score5
WACC5.45%
ROIC/WACC0.09
Cap/Depr(3y)119.46%
Cap/Depr(5y)96.76%
Cap/Sales(3y)1.78%
Cap/Sales(5y)1.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.68%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-6.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-84.43%
EBIT growth 3Y-56.84%
EBIT growth 5Y-20.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-119.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-50.05%
OCF growth 3Y-31.13%
OCF growth 5Y-10.17%
CHS INC - CHSINC 7.1 PERP / CHSCN FAQ
What is the ChartMill fundamental rating of CHS INC - CHSINC 7.1 PERP (CHSCN) stock?
ChartMill assigns a fundamental rating of 3 / 10 to CHSCN.
Can you provide the valuation status for CHS INC - CHSINC 7.1 PERP?
ChartMill assigns a valuation rating of 1 / 10 to CHS INC - CHSINC 7.1 PERP (CHSCN). This can be considered as Overvalued.
What is the profitability of CHSCN stock?
CHS INC - CHSINC 7.1 PERP (CHSCN) has a profitability rating of 4 / 10.
What is the financial health of CHS INC - CHSINC 7.1 PERP (CHSCN) stock?
The financial health rating of CHS INC - CHSINC 7.1 PERP (CHSCN) is 3 / 10.